Technical Analysis for SLP - Simulations Plus, Inc.

Grade Last Price % Change Price Change
B 50.37 -1.15% -0.59
SLP closed up 1.48 percent on Friday, May 17, 2024, on 52 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
NR7 Range Contraction -1.15%
Upper Bollinger Band Walk Strength -1.15%
Overbought Stochastic Strength -1.15%
New Uptrend Bullish 0.32%
Slingshot Bullish Bullish Swing Setup 0.32%
Upper Bollinger Band Walk Strength 0.32%
Multiple of Ten Bullish Other 0.32%
Overbought Stochastic Strength 0.32%
Upper Bollinger Band Touch Strength 0.32%
Shooting Star Candlestick Bearish 0.23%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Simulations Plus, Inc. Description

Simulations Plus, Inc. designs and develops pharmaceutical simulation software for use in the pharmaceutical research and in the education of pharmacy and medical students. The company's products include ADMET Predictor, a computer program that takes molecular structures as inputs and predicts their properties; MedChem Designer, a molecule drawing program or sketcher; MedChem Studio, a tool for data mining and designing new drug-like molecules by medicinal and computational chemists; DDDPlus, which simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives contained in tablets and capsules; and GastroPlus that simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs administered to humans and animals. It also develops and sells Abbreviate!, a productivity software program, as well as offers consulting and contract research services to the pharmaceutical industry. The company operates in North America, Europe, Asia, and South America. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.


Classification

Sector: Technology
Industry: Health Information Services
Keywords: Health Sciences Pharmacy Pharmacology In Vitro Pharmaceutical Sciences Medicinal Chemistry Lancaster Pharmacokinetics Software Program Simulation Software Contract Research Services Data Mining Pharmaceutical Research Pharmacodynamics

Is SLP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 52.4456
52 Week Low 32.7665
Average Volume 108,023
200-Day Moving Average 42.14
50-Day Moving Average 45.37
20-Day Moving Average 47.48
10-Day Moving Average 49.14
Average True Range 1.31
RSI (14) 70.85
ADX 26.58
+DI 32.76
-DI 12.55
Chandelier Exit (Long, 3 ATRs) 47.28
Chandelier Exit (Short, 3 ATRs) 48.08
Upper Bollinger Bands 51.20
Lower Bollinger Band 43.76
Percent B (%b) 0.97
BandWidth 15.66
MACD Line 1.44
MACD Signal Line 1.16
MACD Histogram 0.2804
Fundamentals Value
Market Cap 1.02 Billion
Num Shares 20 Million
EPS 0.53
Price-to-Earnings (P/E) Ratio 96.13
Price-to-Sales 13.33
Price-to-Book 4.81
PEG Ratio 9.77
Dividend 0.24
Dividend Yield 0.47%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 52.03
Resistance 3 (R3) 51.91 51.43 51.85
Resistance 2 (R2) 51.43 51.15 51.49 51.79
Resistance 1 (R1) 51.19 50.98 51.31 51.31 51.73
Pivot Point 50.71 50.71 50.77 50.77 50.71
Support 1 (S1) 50.47 50.44 50.59 50.59 50.17
Support 2 (S2) 49.99 50.27 50.05 50.11
Support 3 (S3) 49.75 49.99 50.05
Support 4 (S4) 49.87